The cartilaginous tissue formation using sry (Sex Determining Region Y)-BOX9

and telomerase reverse transcriptase genes transfected chondrocytes: in vivo

approach by Noorhidayah Md Nazir, et al.
Sains Malaysiana 49(5)(2020): 1067-1080
http://dx.doi.org/10.17576/jsm-2020-4905-11
The Cartilaginous Tissue Formation using Sry (Sex Determining Region Y)-BOX9 
and Telomerase Reverse Transcriptase Genes Transfected Chondrocytes: In vivo 
Approach 
(Pembentukan Tisu Tulang Rawan menggunakan Sry (Penentu Jantina Rantau Y)-BOX9 dan Telomerase Gen 
Transkripsi Berbalik Kondrosit Transfeksi: Pendekatan in vivo)
NOORHIDAYAH MD NAZIR, AHMAD HAFIZ ZULKIFLY, KAMARUL ARIFFIN KHALID, ISMAIL ZAINOL, 
ZAITUNNATAKHIN ZAMLI & MUNIRAH SHA’BAN*
ABSTRACT
The shortage of organ supply reduces the success rate of organ transplantation. Hence, tissue regeneration has been 
initiated with the intention of improving the available treatment modalities. Articular cartilage is a suitable tissue for this 
purpose due to its limited self-heal ability. This study aims to evaluate the cartilaginous properties of in vivo constructs 
formed using chondrocytes transfected with the combination of sry (sex determining region y)-box9 (SOX9) and 
telomerase reverse transcriptase (TERT) genes (SOX9/TERT-transfected chondrocytes) seeded on a three-dimensional 
(3D) poly(lactic-co-glycolic) acid (PLGA)-based scaffold. The rabbit’s articular chondrocytes (n=6) were transfected 
with SOX9 and TERT genes via lipofection. The non-transfected chondrocyte (NTC) was used as a control. A total of 
1×105 cells were seeded on a PLGA and PLGA/fibrin hybrid scaffolds to form constructs. The resulted constructs were 
SOX9/TERT-PLGA/fibrin, NTC-PLGA/fibrin, SOX9/TERT-PLGA and, NTC-PLGA. All constructs were cultured for three 
weeks prior to subcutaneous implantation into the athymic mice for two and four weeks. The constructs’ structural and 
functional aspects were evaluated using macroscopic observation, compression-stress analysis, histology, quantitative 
sulphated glycosaminoglycan (sGAG) assay and cartilage-specific genes (ACAN, COL2A1, SOX9), TERT, and MMP13 
expression analysis. The constructs demonstrated a cartilage-like appearance. The constructs’ rigidity corresponded to 
the homogenous cells and extracellular matrix distribution in the week-4 constructs. Correspondingly, the cartilaginous 
matrix components were visualised at the pericellular matrix region of the construct, supported by the increment of 
quantitative sGAG content. The SOX9/TERT-PLGA/fibrin exhibited better genes expression and cartilaginous phenotypes 
than the other construct groups. The SOX9/TERT-PLGA/fibrin construct facilitated cartilaginous tissue formation.
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ABSTRAK
Kekurangan bekalan organ menurunkan kadar kejayaan pemindahan organ. Oleh itu, penjanaan semula tisu telah 
diusahakan bagi memperbaiki modaliti rawatan sedia ada. Rawan artikul ialah tisu yang sesuai untuk kegunaan ini 
oleh sebab kebolehan swapulihnya yang terbatas. Kajian ini bertujuan untuk menilai ciri-ciri tulang rawan binaan in 
vivo yang dibentuk melalui transfeksi gabungan gen sry (penentu jantina rantau y)-box9 (SOX9) dan gen telomerase 
transkriptase membalik (TERT) ke dalam sel kondrosit yang disemai atas kerangka tiga dimensi (3D) berasaskan asid 
poli(laktik-ko-glikolik) (PLGA). Sel kondrosit artikul arnab (n=6) telah ditransfeksi dengan gen SOX9 dan TERT melalui 
kaedah lipofeksi. Sel kondrosit tanpa transfeksi (NTC) telah digunakan sebagai kawalan. Sejumlah 1×105 sel telah 
disemai atas kerangka PLGA 3D dan kerangka hibrid PLGA/fibrin untuk membentuk binaan. Binaan yang terhasil ialah 
SOX9/TERT-PLGA/fibrin, NTC-PLGA/fibrin, SOX9/TERT-PLGA dan NTC-PLGA. Semua binaan telah dikultur selama 
tiga minggu sebelum diimplantasi secara subkutaneus ke dalam tikus tanpa timus selama dua dan empat minggu. 
Aspek struktur dan fungsian binaan telah dinilai menggunakan pemerhatian makroskopik, analisis tegasan mampatan, 
histologi, asai kuantitatif glikosaminoglikan sulfat (sGAG) dan analisis ekspresi gen khusus tulang rawan (ACAN, 
COL2A1, SOX9), TERT dan MMP13. Binaan menunjukkan rupa tulang rawan. Ketegaran binaan sejajar dengan 
taburan sel homogen dan matriks ekstrasel pada binaan minggu ke-4. Komponen matriks tulang rawan telah dilihat 
pada binaan di bahagian matriks periselular, disokong oleh kenaikan kandungan kuantitatif sGAG. SOX9/TERT-PLGA/
fibrin mempamerkan ekpresi gen dan fenotip tulang rawan yang lebih baik berbanding kumpulan binaan yang lain. 
Binaan SOX9/TERT-PLGA/fibrin memudahkan pembentukan tisu tulang rawan. 
Kata kunci: In vivo; sel kondrosit; SOX9; TERT; transfeksi; tulang rawan
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INTRODUCTION
The establishment of cell culture helps the researchers 
to study the cells’ behaviour. A recognised cartilage 
repair treatment modality, autologous chondrocyte 
implantation (ACI) applies cell culture technique using 
the retrieved chondrocytes from the damaged cartilage 
site (Ogura et al. 2019). The cultured chondrocytes are 
implanted to the site with the hope that new tissue will grow 
at the defected area. However, the fate of the implanted cell 
is unknown because it has been indicated that the cultured 
chondrocytes tend to dedifferentiate in monolayer culture 
(Kavand et al. 2019; Mohd Yunus et al. 2019; Vermeulen 
et al. 2019).  
The introduction of tissue engineering and 
regenerative medicine (TERM) gives hope to improve 
the existing medical intervention, particularly for treating 
cartilage damage. In TERM, tissue regeneration is 
achieved by incorporating the cells into the 3D scaffold 
with the supplementation of signalling cues. Hence, the 
3D culture setting is expected to provide a better implant 
quality than the monolayer culture because the cultured 
cells are developing towards functioning tissue (Prosser 
et al. 2019). It shows the importance of cells interaction 
in the scaffold as the formed construct mimics the tissue 
in its actual condition, that is in the form of multicellular 
layers. Several cartilage TERM studies have demonstrated 
cartilaginous phenotype restoration in the in vitro 
cultured construct (Kudva et al. 2018; Liu et al. 2019; 
Elakkiya et al. 2019). Hence, the confirmation of tissue 
development in the in vitro construct has to be analysed in 
the in vivo setting, as it is close to an actual environment. 
For instance, it has been reported that the implanted 
construct in an ectopic animal model (athymic mice) 
has exhibited positive tissue growth  in just four weeks 
(Deng et al. 2019; Joydip et al. 2013), six weeks (Zhang 
et al. 2019), seven weeks (Zhu et al. 2014)chondrocytes 
can maintain stable chondrogenic phenotype in ectopic 
microenvironment, which was speculated to be related 
with the existence of anti-angiogenic factors such as 
Chondromodulin-I (Chm-I and eight weeks (Sabatino et 
al. 2012) post-implantation. 
In this study, the construct is formed by seeding 
the chondrocytes transfected with SOX9 and TERT genes 
(SOX9/TERT-transfected chondrocytes) in PLGA/fibrin 
and PLGA scaffolds. SOX9 is the chondrogenesis master 
regulator which activates other cartilaginous markers, 
namely collagen type-II and aggrecan and suppresses 
hypertrophy marker, collagen type-X in non-hypertrophic 
chondrocytes (Zhang et al. 2017). In the case of TERT, 
it is anticipated to delay the apoptosis or senescence 
of the cells. The potential of SOX9/TERT-transfected 
chondrocytes has been verified in the ex vivo experimental 
setting (Noorhidayah et al. 2019). The finding has 
demonstrated the formation of cartilaginous tissue with 
a stable phenotypic expression in the construct that has 
been formed using SOX9/TERT-transfected chondrocytes 
compared to the other cell groups. However, the tissue’s 
histoarchitecture has not fully occupied or infiltrated into 
the porous scaffold. As a continuation of the report, this 
study aims to evaluate the constructs’ performance in the 
in vivo environment. 
MATERIALS AND METHODS
CHONDROCYTES ISOLATION
With the approval of the Institutional Animal Care 
and Use Committee, International Islamic University 
Malaysia (IACUC-IIUM) (IIUM/IACUC/Approval 2015/
[5]/[24]), the 6-months old New Zealand White rabbits 
(n=6) were obtained from a commercially available 
source in Kuantan, Pahang. Articular cartilage was 
aseptically harvested from the femoral condyle and 
tibial plateau. The chondrocytes isolation procedure was 
conducted as described in Noorhidayah et al. (2019). 
The cultured cells were supplemented with 1:1 of Ham’s 
F12 nutrient mixture (F12) and Dulbecco’s Modified 
Eagles Medium (DMEM) culture medium supplemented 
with 1% (v/v) AA (Gibco, Grand Island, NY), 10% (v/v) 
Fetal Bovine Serum (FBS) (Gibco, Grand Island, NY), 
1% (v/v) GlutaMAXTM (Gibco, Grand Island, NY), 1% 
(v/v) 4-(2-hydroxyethyl)-1-piperazineethanesufonic acid 
(HEPES) buffer (Gibco, Grand Island, NY) and 1% (v/v) 
50 µg/mL of ascorbic acid (Sigma-Aldrich, St. Louis, 
Missouri, USA). The cultures were maintained in a 5% 
CO2 incubator (Thermo Scientific, Barnstead Lab Line, 
USA) at 37 °C. The cells were sub-cultured to passage-1 
(P1) once it reached 70%-90% confluency.
SOX9 AND TERT GENES TRANSFECTION
The P1 cells were transfected with pcDNA3-SOX9 
and/or pBABE-neo-hTERT plasmids via lipofection 
(LipofectamineTM 3000, Invitrogen, CA, USA) by 
following the manufacturer’s protocol (Noorhidayah 
et al. 2019). The procedure managed to achieve the 
transfection efficiency of 60.38% (unpublished data). The 
cells were grouped into (a) non-transfected chondrocytes 
(NTC, control)  and (b) SOX9 /TERT-transfected 
chondrocytes. The cells were detached from the culture 
plate with Trypsin-ethylenediaminetetraacetic acid 
(EDTA) (Gibco, Grand Island, NY, USA) after 24 h and 
were seeded in the scaffold.
FORMATION OF 3D CONSTRUCT
The disc-shaped (3 mm height × 7 mm diameter) 20% 
(w/v) PLGA (mole ratio: 65:35, Resomer RG653H, 
Sigma-Aldrich, St. Louis, Missouri, USA) scaffold 
with the pore size of 180 µm-250 µm, 85.2% porosity 
was fabricated using solvent casting and salt leaching 
technique (Munirah et al. 2008a; Noorhidayah et al. 
2019). The SOX9/TERT-transfected chondrocytes and 
NTC at P1 were seeded into a sterilised PLGA scaffold 
with and without rabbit’s plasma-derived fibrin with the 
concentration of 865,800 cell/cm3 (100,000 cells per 7 
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mm × 3 mm scaffold) (Table 1). The cells seeded in the 
PLGA with 250 µL fibrin was coagulated by adding 50 
µL calcium chloride (CaCl2) (Sigma-Aldrich, St. Louis, 
Missouri, USA). The formed constructs were cultured for 
three weeks in vitro. 
TABLE 1. The experimental groups and relevant abbreviations
Scaffolds Cells Source Abbreviation Used
PLGA and fibrin
seeded 
with
SOX9 and TERT-transfected chondrocytes SOX9/TERT-PLGA/fibrin(S/T-P/F)
Non-transfected chondrocytes NTC-PLGA/fibrin (C-P/F)
PLGA
*without fibrin SOX9 and TERT-transfected chondrocytes
SOX9/TERT-PLGA
 (S/T-P)
Non-transfected chondrocytes NTC-PLGA (C-P)
CONSTRUCT IMPLANTATION
The in vitro cultured constructs were implanted 
subcutaneously at the dorsum of 6-week old athymic 
mice (n= 6). General anaesthesia was carried out with 
an intramuscular injection of zoletil (25 mg/kg) (Virbac 
Laboratories, Carros, France) and xylazine (12 mg/
kg) (Ilium, Troy Laboratories Pty Limited, Australia) 
(ZX) cocktail (Choi & Jeong 2017). Under the aseptic 
condition, four subcutaneous pockets were created 
per mouse by making a small horizontal incision 
(approximate of 1 cm) on the dorsum of the mouse’s skin. 
The four pockets were created by manoeuvring a blunt 
surgical scissor, enough to fit a 7 mm × 3 mm scaffold in 
the pocket. The construct was carefully inserted in each 
pocket and sutured with resorbable stitches, 3.0 Vicryl 
(Johnson & Johnson Healthcare System. Inc., Hoes Lane, 
Piscataway, New Jersey, USA). The mice were allowed 
to move freely in an individually ventilated cage (IVC). 
The in vivo constructs were harvested at week-2 and 
week-4 by overdosing the mice with the ZX cocktail.
MACROSCOPIC OBSERVATION
The constructs were observed at room temperature for 
its gross appearance, shape, and colour. Simple palpation 
using forceps was conducted to confirm the construct’s 
rigidity (Alsberg et al. 2002).
COMPRESSION-STRESS ANALYSIS
The analysis was conducted using a biomechanical-
testing machine (Instron E300, Oswald Elektromotoren 
GmbH, Germany). The construct was stored in normal 
saline before testing. A constant compressive strain rate 
of 1 mm/min was applied until failure, and a stress-strain 
curve was generated. The generated data was used to plot 
the result. 
HISTOLOGICAL STAINING
The construct was fixed in 10% Neutral Buffered 
Formalin (NBF) (Surgipath®, Leica Microsystem, USA), 
processed and sectioned to 5 µm. Haematoxylin and 
eosin (H&E) (Haematoxylin 560MX®, Leica Biosystem 
Richmond Inc, Canada), alcian blue, pH 2.5 (Merck 
KGaA, Darmstadt, Germany), toluidine blue, pH 1.0 
(Sigma-Aldrich, St. Louis, Missouri, USA) and 0.1% 
safranin O (Merck KGaA, Darmstadt, Germany) were 
conducted to observe the structural and functional aspects 
of the construct. 
QUANTITATIVE sGAG ASSAY
The construct was digested in 125 µg/mL papain enzyme 
(Sigma-Aldrich, St. Louis, Missouri, USA) for 16 h at 
60 °C. The sGAG detection was conducted using Alcian 
Blue assay by following the procedure in Karlsson and 
Björnsson (2001), as described in Noorhidayah et al. 
(2019). The absorbance was measured using a VersaMax 
microplate reader (Molecular Devices, San Jose, 
California, USA) at 620nm. The data were normalised 
with the construct’s dry weight. 
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CARTILAGINOUS MARKERS EXPRESSION ANALYSIS
SOX9, aggrecan (ACAN) and collagen type-II (COL2A1), 
collagen type-I (COL1A2), TERT and MMP13 genes 
expression were evaluated using real-time polymerase 
chain reaction (RT-PCR). The primers are listed in Table 
2. The reaction was conducted using CFX96 TouchTM 
Real-Time PCR Detection System (BIO RAD, Hercules, 
California, USA). The PCR profile for the respective 
markers are as follows: initial denaturation, 95 °C for 5 
min, 39 cycles of 95 °C for 5 s and 60.3 °C for 30 s. 
TABLE 2. The used molecular markers primer sequences 
Primer’s name Sequences Accession number PCR 
product 
(bp)
HPRT1 F:5’-GCA GAC CTT GCT TTC CTT GGT-3’ NM_001105671.1 62
R:5’-GCA GGC TTG CGA CCT TGA C-3’
COL1A2 F:5’-GGT GGT TAC GAC TTT GGT TA-3’ NM_001195668.1 95
R:5’-GCA TCG ACT TCA TAG TCC TT-3’
COL2A1 F:5’-TGC AGG AGG GGA AGA GGT AT-3’ NM_001195671.1 123
R:5’-GGC AGT CCT TGG TGT CTT CA-3’
ACAN F:5’-ACA CTG GCG AGT ACT GTG AC-3’ XM_008251722.2 95
R:5’-TGT GAA AGA GTC GCT GGC AT-3’
SOX9 F:5’-AAG ATG ACC GAC GAG CAG GA-3’ XM_008271763.2 116
R:5’-CGT GTA TTC TCG GTG TCG GA-3’
TERT F:5’-TTG CGG AAG ACA GTG GTG AA-3’ NM_198253.2 176
R:5’-AGA CTG GCT CTG ATG GAG GT-3’
STATISTICAL ANALYSIS
From the compression-stress analysis, sGAG assay 
and cartilaginous markers expression, the data were 
expressed as the mean ± standard error of the mean. The 
data was tested with the Shapiro-Wilk normality test. 
Mixed-design ANOVA was used with p<0.05 that was 
considered statistically significant.
RESULTS AND DISCUSSION
CARTILAGE-LIKE TISSUE MORPHOLOGY
Cartilage TERM approach is perceived as a hope to solve 
cartilage damage or degeneration issue. A reproducible 
cartilaginous tissue implant formation is the ultimate 
goal for any cartilage TERM attempt. Hence, the 
evaluation of structural and functional aspects of the 
construct confirmed the construct’s potential. In terms of 
the construct’s macroscopic morphology, the in vitro and 
in vivo constructs had retained the disc-shaped structure 
and were reduced in their diameter as the time point 
increased (Figure 1). The in vivo constructs appeared 
to have a smoother, glossier surface and were more 
cartilage-like than the in vitro constructs. In addition, no 
significant difference has been noted between the PLGA/
fibrin and PLGA scaffold groups. Based on the resulted 
construct’s morphology, it is possible that the secreted 
ECM has replaced the degraded biomaterial scaffold and 
are left with the formed tissue. Besides that, the scaffold 
size-reduction was perhaps affected by the in vivo 
microenvironment because of its ectopic implantation 
site. Although it was not implanted at the actual site, 
this cartilaginous tissue was able to grow under the skin. 
Hence, it is suggested that the chances of the construct to 
form cartilaginous tissue in the actual site of implantation 
may be high.
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FIGURE 1. a) The representative images of in vitro construct gross morphology at week-1, 
week-2 and week-3, b) The representative images of in vivo construct at week-2 and week-4 & 
c) The mechanical strength of the in vivo construct at week-2 and week-4. *represents p < 0.05 
that is considered as significant. The constructs abbreviation is listed in Table 1
THE INCREMENT OF CONSTRUCT’S RIGIDITY INFLUENCED 
BY TISSUE’S HISTOARCHITECTURE
A simple palpation test conducted on the in vivo construct 
indicated the increment of the construct’s rigidity from 
week-2 to week-4 post-implantation (Figure 1(c)). The in 
vitro constructs were unable to retain its 3D structure and 
collapse upon palpation. The post-implanted construct’s 
rigidity outcome was confirmed via compression-stress 
analysis. Regardless of scaffold groups, it was noted 
that the mechanical strength at week-4 of all in vivo 
construct was higher than the construct’s strength at 
week-2. The mechanical strength of the construct groups 
had increased by 1.06-times, 1.04-times, 1.05-times, 
1.07-times in SOX9/TERT-PLGA/fibrin, SOX9/TERT-PLGA, 
NTC-PLGA/fibrin, and NTC-PLGA, respectively. There 
were no significant differences between each week, 
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F(1.00,5.00)=4.42, p>0.05. There was also no significant 
differences between each group, F(3.00,15.00)=0.91, 
p>0.05. There was no significant interaction between 
weeks and groups, F(3.00,15.00)=0.42, p>0.05.
Based on the result, it is noted that the construct’s 
structure at week-2 is more porous than the construct at 
week-4 due to the lower mechanical strength value. It is 
believed that the cells interaction and ECM distribution 
contribute to the mechanical strength of the in vivo 
constructs (Wang et al. 2016). As supported by the 
histological visualisation (Figure 2(a)), less-homogenous 
cells and ECM infiltration had been observed in the 
construct at week-2, while the week-4 construct 
structure was wholly occupied with the matrix. From 
the visualisation, the resulted histoarchitecture of the 
week-4 construct was comparable with the one that was 
reported at week-16 post-implantation (Calabrese et al. 
2017), indicating the cells dynamic interaction with the 
in vivo environment. While the in vitro cartilaginous 
tissue was formed thinly on the outer part of the 
scaffold corresponded to the unstable in vitro construct 
structure caused by the incomplete cells and matrix 
infiltration (Noorhidayah et al. 2019). In addition, 
there was no significant difference in terms of cartilage 
histoarchitecture formation in both PLGA/fibrin and 
PLGA scaffold groups.
THE INCREASE OF CARTILAGINOUS MATRIX COMPONENT 
PRODUCTION IN THE IN VIVO CONSTRUCT
The cartilaginous matrix components (sGAG and 
proteoglycan) secretion were in its infant state in the in 
vivo construct, even though the construct had exhibited 
cartilage histoarchitecture formation with distinct 
chondrocytes morphology in the matrix. 
The blue stain of alcian blue representing positive 
sGAG indicator was visualised at the pericellular 
matrix region of the in vivo and in vitro constructs 
at all designated time points (Figure 2(b)). The sGAG 
was concentrated at the pericellular matrix region 
with less-homogenous distribution in the constructs. 
The distribution of sGAG in the matrix showed that 
the secretion of sGAG was still in its primitive stage 
in the in vivo construct, indicating that the formed 
cartilaginous tissue was young. In addition, the intense 
alcian blue stain in the week-4 constructs was a sign 
that the formed cartilaginous tissue was progressing 
towards maturation. The histological outcome was 
supported by the quantitative sGAG content increment 
in the in vivo construct (Figure 2(c)). The sGAG content 
had increased by 1.40-times, 1.54-times, 2.55-times, 
1.64-times in SOX9/TERT-PLGA/fibrin, SOX9/TERT-
PLGA, NTC-PLGA/fibrin and NTC-PLGA, respectively. 
There was no significant difference between each week, 
F(1.00,5.00)=1.77, p>0.05. There was also no significant 
difference between each group, F(3.00,15.00)=1.69, 
p>0.05. There was no significant interaction between 
weeks and groups, F(3.00,15.00)=0.15, p>0.05. There 
was an increment of quantitative sGAG content in the in 
vitro constructs (Noorhidayah et al. 2019). It showed that 
the sGAG had continuously been produced in both the in 
vitro and in vivo constructs as the time point increased.
The sGAG production stimulates the presence of 
proteoglycan in the matrix as it is made up of sGAG 
chains that are bonded with a core protein. In this 
study, proteoglycan visualisation through toluidine 
blue corresponds to the sGAG histological outcome. 
The dark purple stain of toluidine blue was detected 
at the pericellular matrix region in the in vivo and in 
vitro constructs (Figure 3(a)). As for the proteoglycan 
detection through safranin O, an intense orange-red 
stain was displayed in the in vitro constructs indicating 
the presence of proteoglycan-rich matrix. In the in 
vivo constructs, the protein was more visible at the 
pericellular matrix region of week-4 in the SOX9/TERT-
PLGA/fibrin compared to the other groups (Figure 3(b)). 
The low detection of proteoglycan through safranin 
O is expected due to the stain having a low affinity 
towards sulphur in the tissue that can only be detected in 
mature cartilage (Schmitz et al. 2010). From the overall 
histology visualisation, it can be noted that the in vivo 
construct is a premature cartilaginous tissue.
Besides that, the presence of collagen type-II 
and collagen type-I were detected in the construct 
via immunohistochemistry staining (Figure 4). The 
immunopositivity of collagen type-II was noted in the 
in vitro and in vivo constructs with the accumulation of 
brown precipitation at the pericellular matrix region. 
Collagen type-II was expressed in all constructs at all 
designated time points. The collagen’s immunoreaction 
was particularly homogenous in SOX9/TERT-PLGA/
fibrin compared to other constructs. As for the collagen 
type-I immunoreaction, the collagen was expressed in 
the in vitro setting. However, the brown precipitation 
was not visible at the pericellular matrix region in all in 
vivo constructs. Among all the constructs, SOX9/TERT-
PLGA/fibrin at week-4 had shown prominent negative 
collagen type-I immunoreaction. 
Collagen type-II is a specific marker for hyaline 
cartilage and only presented in the mature cartilage. 
Despite that, the co-expression of collagen type-II and 
collagen type-I is known to be a sign of the developing 
cartilage (Munirah et al. 2008b; Noorhidayah et 
al. 2019), which is based on the previous rat tibial 
articular cartilage development study (Sasano et al. 
1996). This event is noted in the 3D culture outcome 
which highlights the phenotypically immature in vitro 
cartilaginous tissue. Even so, the tissue is progressing 
towards maturation as the ectopic implanted construct 
has shown its potential as hyaline cartilage with the 
non-detected immunopositivity of collagen type-I in the 
groups. 
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FIGURE 2. a) The images show the morphology or histoarchitecture of the in vivo construct 
that has been stained using haematoxylin and eosin, b) The presence of sGAG at the peri-
cellular matrix region is indicated as the blue stain in the in vivo ‘construct that has been 
stained using alcian blue’. Magnification = 200X. Scale bar = 100 µm (yellow coloured) & 
c) The quantitative sGAG content increment in the in vivo construct. *represents p < 0.05 
that is considered as significant. The constructs abbreviation is listed in Table 1
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FIGURE 3. a) The presence of proteoglycan at the pericellular matrix region of the in vivo 
construct is indicated as the dark purple stain of toluidine blue & b) The presence of proteo-
glycan at the pericellular matrix region of the in vivo construct is indicated as the orange-
red stain of safranin O has been detected, particularly in SOX9/TERT-PLGA/fibrin at week-4. 
The arrows indicate the accumulation of proteoglycan at the pericellular matrix region. 
Magnification = 200X. Scale bar = 100 µm (yellow coloured). The constructs abbreviation 
is listed in Table 1
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FIGURE 4. a) The brown precipitation indicates the presence of collagen type-II at the peri-
cellular matrix region of the in vivo construct using immunohistochemistry & b) The brown 
precipitation indicates the presence of collagen type-I at the pericellular matrix region of 
the in vivo construct that has not been detected, particularly in SOX9/TERT-PLGA/fibrin at 
week-4. Magnification = 200X. Scale bar = 100 µm (yellow coloured). The constructs ab-
breviation is listed in Table 1
THE UPREGULATION OF CARTILAGINOUS MARKERS 
EXPRESSION IN SOX9/TERT-PLGA/FIBRIN CONSTRUCT
The gene expression result demonstrated the upregulation 
of proteoglycan marker, ACAN in the in vivo SOX9/TERT-
PLGA/fibrin construct (Figure 5(a)). The gene expression 
was upregulated from 1.00±0.51-fold at week-2 to 
3.63±0.58-fold at week-4 in the construct group, by 
3.63-times. The ACAN expression result indicates that 
there was no significant difference between each week, 
F(1.00,5.00)=0.58, p>0.05. There was also no significant 
difference between each group, F(3.00,15.00)=2.71, 
p>0.05. There was no significant interaction between 
weeks and groups, F(3.00,15.00)=2.71, p>0.05. The ACAN 
expression level in SOX9/TERT-PLGA/fibrin corresponds 
to the histological visualisation, as the proteoglycan rich-
matrix was visibly increased in the construct through 
safranin O (the mature cartilage detector). In the in vitro 
constructs, the gene expression was also significantly 
upregulated in the SOX9/TERT-PLGA/fibrin (Noorhidayah 
et al. 2019).
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Similar with ACAN expression the in vivo construct, 
COL2A1 expression was upregulated in the SOX9/
TERT-PLGA/fibrin. The upregulation of COL2A1 
gene expression was from 1.00±0.76-fold at week-
2 to 4.63±1.81-fold at week-4 (Figure 5(b)). There 
was no significant difference between each week, 
F(1.00,5.00)=2.48, p>0.05. There was also no significant 
difference between each group, F(1.11,5.53)=2.57, 
p>0.05. There was no significant interaction between 
weeks and groups, F(1.11,5.53)=2.57, p>0.05. The gene 
was also upregulated in the in vitro constructs made of 
SOX9/TERT-transfected chondrocytes, which were SOX9/
TERT-PLGA/fibrin and SOX9/TERT-PLGA (Noorhidayah 
et al. 2019).
The upregulation of SOX9 gene in the in vivo SOX9/
TERT-PLGA/fibrin was expected as both ACAN and 
COL2A1 were well-expressed in the construct (Figure 
5(c)). SOX9 gene expression was increased by 3.52-times 
in the construct group. There was no significant 
difference between each week, F(1.00,5.00)=0.01, 
p>0.05. There was a significant difference between 
each group, F(3.00,15.00)=4.21, p<0.05. Among the 
FIGURE 5. a) ACAN gene expression was upregulated in the in vivo SOX9/TERT-PLGA/
fibrin, b) COL2A1 gene expression was upregulated in the in vivo in SOX9/TERT-PLGA/
fibrin, c) SOX9 gene expression was upregulated in the in vivo SOX9/TERT-PLGA/fibrin, 
d) COL1A2 gene expression was upregulated in the in vivo SOX9/TERT-PLGA/fibrin and 
NTC-PLGA, e) TERT gene expression was upregulated in the in vivo SOX9/TERT-PLGA/
fibrin and NTC-PLGA & f) MMP13 gene expression was upregulated in the in vivo SOX9/
TERT-PLGA/fibrin and NTC-PLGA/fibrin. *represents p < 0.05 that is considered as sig-
nificant. The constructs abbreviation is listed in Table 1
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construct groups, there was a difference between SOX9/
TERT-PLGA and SOX9/TERT-PLGA/fibrin. There was 
also a significant interaction between weeks and groups, 
F(3.00,15.00)=4.21, p<0.05. In the in vitro setting, the 
gene’s upregulation pattern was shared with the constructs 
that were formed using SOX9/TERT-transfected 
chondrocytes, SOX9/TERT-PLGA/fibrin, and SOX9/TERT-
PLGA (Figure 6(a)). There was a significant difference 
between each week, F(1.06,5.31)=36.35, p<0.05. Among 
the constructs, there was also a significant difference 
between each group, F(7=1.60,8.01)=82.55, p<0.05. 
There was a significant interaction between weeks and 
groups, F(1.94,9.71)=38.07, p<0.05.
FIGURE 6. a) SOX9 gene expression was upregulated in the in vitro SOX9/TERT-PLGA/fibrin 
and SOX9/TERT-PLGA, b) TERT gene expression was upregulated in the in vitro SOX9/TERT-
PLGA/fibrin and SOX9/TERT-PLG & c) MMP13 gene expression was upregulated in the in 
vitro SOX9/TERT-PLGA/fibrin and SOX9/TERT-PLGA. *represents p < 0.05 that is considered 
as significant. The constructs abbreviation is listed in Table 1
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In the in vivo constructs, COL1A2 expression was 
upregulated in SOX9/TERT-PLGA/fibrin 3.17-times and 
6.38-times in NTC-PLGA (Figure 5(d)), even though 
the constructs exhibited negative collagen type-I 
immunoreaction. There was no significant difference 
between each week, F(1.00,5.00)=1.69, p>0.05. There 
was a significant difference between each group, 
F(1.70,8.48)=5.73, p<0.05. Among the construct 
groups, there was a difference between NTC-PLGA 
and NTC-PLGA/fibrin with SOX9/TERT-PLGA. There 
was also a significant interaction between weeks and 
groups, F(1.70,8.48)=5.73, p<0.05. While in the in vitro 
constructs, there were no changes in terms of COL1A2 
expression in SOX9/TERT-PLGA/fibrin (Noorhidayah et 
al. 2019). 
As for the TERT expression in the in vivo constructs, 
the gene was upregulated in SOX9/TERT-PLGA/fibrin 
by 14.40-times and NTC-PLGA by 3.21-times (Figure 
5(e)). There was a significant difference between each 
week, F(1.00,5.00)=9.18, p>0.05. There was a significant 
difference between each group, F(3.00,15.00)=6.10, 
p<0.05. Among the construct groups, there was a 
difference between SOX9/TERT-PLGA/fibrin and NTC-
PLGA/fibrin with SOX9/TERT-PLGA. There was also 
a significant interaction between weeks and groups, 
F(3.00,15.00)=6.10, p<0.05. While in the in vitro 
setting, the gene was upregulated in SOX9/TERT-PLGA/
fibrin and SOX9/TERT-PLGA in the culture. There 
was no significant difference between each week, 
F(1.06,5.32)=5.59, p>0.05. Among the construct 
groups, there was a significant difference between 
each group, F(2.90,14.52)=132.28, p<0.05. There was 
a significant interaction between weeks and groups, 
F(3.11,15.53)=52.28, p<0.05. The regulation of TERT in 
the constructs indicates that the cells have the potential 
in maintaining its lifespan longer than other constructs 
because the expressed gene is expected to decelerate the 
shortening of the telomere sequences during cell division 
and ultimately delay the apoptosis or senescence of the 
cells. 
The expression of a cartilage-breakdown marker, 
MMP13 is also being analysed in both in vitro and 
in vivo constructs. MMP13 targets collagen type-II, 
proteoglycan, collagen type-IV, collagen type-IX, 
osteonectin and perlecan which potentially induces 
arthritis, osteoarthritis and other tissue degrading 
diseases (Inada et al. 2004; Yamamoto et al. 2016). 
However, MMP13 is also involved in embryogenesis, 
morphogenesis, normal tissue remodelling and tissue 
repair (Inada et al. 2004; Yamamoto et al. 2016). In the 
in vitro setting, the gene expression was upregulated 
in SOX9/TERT-PLGA/fibrin, and SOX9/TERT-PLGA by 
4.58-times and 2.18-times, respectively, from week-1 to 
week-3 (Figure 6(c)). There was a significant difference 
between each week, F(2.00,10.00)=114.47, p<0.05. 
Among the construct groups, there was also a significant 
difference between each group, F(7.00,35.00)=61.72, 
p<0.05. There was a significant interaction between weeks 
and groups, F(14.00,70.00)=53.95, p<0.05. While in the 
in vivo construct, MMP13 expression was upregulated 
in SOX9/TERT-PLGA/fibrin and NTC-PLGA/fibrin by 
2.38-times and 1.29-times, respectively (Figure 5(f)). 
There was no significant difference between each week, 
F(1.00,5.00)=0.18, p>0.05. There was a significant 
difference between each group, F(3.00,15.00)=10.61, 
p<0.05. Among the construct groups, there was a 
difference between SOX9/TERT-PLGA/fibrin and 
NTC-PLGA with SOX9/TERT-PLGA. There was also 
a significant interaction between weeks and groups, 
F(3.00,15.00)=10.61, p<0.05. As supported by the co-
expression of the collagens, MMP13 expression in the 
constructs was expected as it was also involved in the 
normal tissue repair and embryonic development. In the 
overall molecular expression analysis, it has been noted 
that the SOX9/TERT-PLGA/fibrin construct has superior 
phenotypic expression compared to the other construct 
groups.
In the previous finding, it has been noted that 
the synergy of SOX9 and TERT genes facilitates the 
restoration of cells’ phenotype in the 3D culture 
(Noorhidayah et al. 2019). As a continuation of the work, 
this study has demonstrated the cartilaginous potential 
of the implanted constructs that have been formed using 
SOX9/TERT-transfected chondrocytes, in particular the 
SOX9/TERT-PLGA/fibrin construct. The finding has also 
noted that the genes are able to maintain the cells’ 
chondrogenic phenotype even with one time transfection 
reaction during monolayer culture (Noorhidayah et al. 
2019). 
The study has incorporated fibrin with PLGA as it 
has been proven to soften the inflammatory response, 
facilitate cell adhesion and proliferation better than 
PLGA only scaffold (Rozlin et al. 2015). Fibrin seems 
to accommodate chondrocytes adaptation in the culture 
medium that may have been affected by the acidic 
PLGA by-product (Lih et al. 2018). Besides, our previous 
report has shown that the PLGA/fibrin scaffold promotes 
better cartilage histoarchitecture than PLGA scaffold in 
vitro (Noorhidayah et al. 2019).
 Based on the histology visualisation, it is noted 
that the in vivo environment facilitates tissue growth in 
stages, where cell proliferation takes place leading to 
tissue maturation which is confirmed by the concentrated 
sGAG and proteoglycan at the pericellular matrix 
region. Nonetheless, a longer implantation period is 
required to observe tissue maturation (structurally 
and functionally) or any possible biological effects to 
the host. It is also suggested to conduct an actual site 
implantation (orthotopic) assessment on the construct 
as the tested biological condition is more accurate, and 
the outcome may differ from ectopic implantation in 
terms of cells migration and cells’ phenotype expression. 
Further investigation on the SOX9/TERT-PLGA/fibrin 
construct is encouraged because it has the potential to be 
commercialised as the tissue-engineered product that will 
contribute to the advancement of organ loss treatment 
modality. 
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CONCLUSION
This study demonstrated the cartilage-like tissue 
formation in the in vivo environment. It is noted that the 
SOX9/TERT-PLGA/fibrin construct has exhibited superior 
phenotypic cartilaginous expression compared to the 
other construct groups. Through histology, the finding 
suggested that the cells in the construct had successfully 
secreted the cartilaginous matrix components. However, 
the formed tissue is still in its infancy and undergoing 
a maturation process. The histoarchitecture difference 
of the constructs in both experimental settings indicates 
that the in vivo setting provides a dynamic environment 
for complete tissue growth compared to the in vitro 3D 
culture. The extended assessment through orthotopic 
implantation is necessary in order to obtain in-depth 
information and understanding of the implanted tissue. 
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